首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1252566

全球數位治療市場-按組件（軟件、設備）、應用（糖尿病、肥胖、心血管、心理/行為健康、高血壓、失眠）、銷售渠道（B2B、B2C）、地區-預測到 2032 年

Digital Therapeutics Market - By Component (Software, Device), By Application (Diabetes, Obesity, Cardiovascular, Mental & Behavioural Health, Hypertension, Insomnia), By Sales Channel (B2B, B2C), By Region - Global Forecast to 2032

出版日期: 2023年03月15日 | 出版商:

Global Market Insights Inc. | 英文 169 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

由於數位療法在醫療保健領域的迅速採用以及提供更優質護理的潛力，預計到 2032 年全球數位療法市場將穩步擴大。

此外，隨著數位治療解決方案成為醫療保健服務的重要組成部分，預計市場收入將顯著增加。技術進步、企業對研究的大量投資以及全球政府鼓勵治療慢性病的運動也促成了這種擴張。

例如，Teladoc Health 於 2022 年 2 月推出了慢性病管理系統 Chronic Care Complete。該系統通過利用連接的健康監測系統並提供廣泛的治療計劃，擴大了對健康教練、醫生和心理健康專家的訪問。這一戰略發布還使公司能夠領先於競爭對手並增加收入。

數位治療市場按組件、應用、銷售渠道和區域進行細分。

在組件方面，推斷設備細分市場將在預測期內獲得顯著的市場份額。數位治療設備因其在慢性病管理中的重要作用而獲得認可，這是這一顯著細分市場擴張的主要因素。數位血糖儀會立即顯示您的血糖是否在範圍內。憑藉藍牙功能、同步移動應用程序和小巧纖薄的設計，客戶可以就他們的健康做出更明智的決定，並開啟新的預防可能性。

從應用來看，從 2023 年到 2032 年，心理和行為健康領域預計將以超過 34% 的複合年增長率增長。這種快速增長歸因於大量精神疾病患者以及在行為和心理健康治療方面的高研發支出。未滿足的醫療需求和大流行病防範帶來的壓力推動了對心理健康解決方案的需求。

按地區劃分，預計歐洲數位療法市場在研究期間將穩步增長。該地區的市場發展受到以下因素的推動：獲得數位療法的機會增加、建立單獨的監管框架以適應 DTx 等尖端療法、政府支持措施、利用率提高和數位療法。它受到以下因素的推動：天使投資人湧入，投資於科技領域的高科技初創企業。

數位治療市場的競爭格局相當成熟。該行業的主要競爭對手包括 Virta Health Corp.、Omada Health、Akili Interactive Labs、Biofourmis, Inc.、Lark Health 等。

內容

第 1 章研究方法和範圍

第 2 章執行摘要

第 3 章數位治療行業洞察

按行業細分
2018-2032 年行業格局
影響行業的因素
- 司機
  - 慢性病增加
  - 越來越需要成本控制
  - 提高護理質量的可能性
  - 數位療法的傳播仍在繼續
- 行業潛在的風險和挑戰
  - 安全和隱私問題
  - 缺乏熟練的 IT 專業人員
增長分析
- 按組件
- 通過申請
- 按銷售渠道
COVID-19 影響分析
數位健康、數位醫學和數位治療之間的區別
監管狀況
- 美國
- 歐洲
贖回場景
- 美國
- 歐洲
投資概覽
技術趨勢分析
領先數位治療公司的研發渠道
按治療領域劃分的數位療法用例和應用
數位療法對主要利益相關者的影響
數位治療 - 生物製藥案例，2019 年版
波特分析
PESTEL 分析

第 4 章競爭格局，2021 年

介紹
2021 年公司矩陣分析
戰略儀表板，2021 年

第 5 章數位治療市場：按組件分類

主要細分趨勢
軟件
設備

第 6 章數位治療市場：按應用

主要細分趨勢
糖尿病
肥胖
心血管系統
心理和行為健康
高血壓
失眠
其他

第 7 章數位治療市場：按銷售渠道

主要細分趨勢
企業對企業 (B2B)
企業對消費者 (B2C)

第 8 章數位治療市場：按地區

主要區域趨勢
北美
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
亞太地區
- 日本
- 中國
- 印度
- 澳大利亞
- 新加坡
拉丁美洲
- 墨西哥
- 巴西
多邊環境協定
- 沙特阿拉伯
- 南非
- 以色列

第九章公司簡介

Otsuka Holdings Co., Ltd.
Propeller Health（ResMed）
Virta Health Corp
Teladoc Health
Pear Therapeutics Inc
Omada Health Inc
Akili Interactive Labs
WellDoc, Inc.
Click Therapeutics
Biofourmis, Inc.
Lark Health
LifeScan, Inc.
DarioHealth
Voluntis
My Sugr（Roche）

簡介目錄圖表

Product Code: 5408

Global Digital Therapeutics Market is slated to expand steadily through 2032 owing to the surging adoption of digital therapeutics in the healthcare sector and its potential to deliver better quality of care.

Additionally, the market revenue is anticipated to increase significantly as digital therapeutics solutions have become a vital part of healthcare delivery. The expansion is also being aided by technological advancements, significant corporate investments in research, and worldwide government campaigns encouraging chronic disease treatment.

For instance, Teladoc Health launched Chronic Care Complete, a chronic condition management system, in February 2022. By utilizing connected health monitoring systems and offering a wide selection of treatment programs, the system expands access to health coaches, doctors, and mental health professionals. The strategic launch also enables the corporation to move ahead in its competition, thus increasing its revenue.

The digital therapeutics market has been divided in terms of component, application, sales channel, and region.

With respect to component, the device segment is speculated to gain substantial market share through the forecast period. Due to their critical function in managing chronic illnesses, digital therapeutic devices have grown in acceptance, which is primarily responsible for this noteworthy segmental expansion. The digital automated blood glucose meters display blood glucose readings that are within or outside the range, immediately. With the Bluetooth-ready, sync mobile app and tiny, slim design, customers can make smarter decisions about their health and have access to new possibilities for prevention.

Based on application, the mental & behavioral health segment is anticipated to grow at more than 34% CAGR from 2023 to 2032. The rapid growth is credited to the large patient population with mental illnesses and significant R&D spending on behavioral and mental health treatments. The demand for mental health solutions has been prompted by significant unmet medical requirements and the stress caused by pandemic mitigation steps.

From the regional front, the Europe digital therapeutics market is expected to proliferate robustly over the review timeline. The market potential in this area is being driven by factors such as growing accessibility to digital therapeutics, the development of a personalized regulatory framework to accommodate cutting-edge modalities such as DTx, supportive government initiatives, rising utilization, and an influx of angel investors funding tech startups in the digital therapeutics space.

The competitive landscape of the digital therapeutics market is considerably established. Some of the major competitors operating in the industry include Virta Health Corp., Omada Health, Akili Interactive Labs, Biofourmis, Inc., Lark Health, and more.

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
- 1.5.1 Secondary
  - 1.5.1.1 Paid sources
  - 1.5.1.2 Unpaid sources
- 1.5.2 Primary

Chapter 2 Executive Summary

2.1 Digital therapeutics industry 360 degree synopsis, 2018-2032
2.2 Business trends
- 2.2.1 Component trends
- 2.2.2 Application trends
- 2.2.3 Sales channel trends
- 2.2.4 Regional trends

Chapter 3 Digital Therapeutics Industry Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018-2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing prevalence of chronic diseases
  - 3.3.1.2 Rising need for cost containment
  - 3.3.1.3 Potential to increase quality of care delivery
  - 3.3.1.4 Growing popularity of digital therapeutics
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Security and privacy issues
  - 3.3.2.2 Lack of skilled IT professionals
3.4 Growth potential analysis
- 3.4.1 By component
- 3.4.2 By application
- 3.4.3 By sales channel
3.5 COVID-19 impact analysis
3.6 Differences between digital health, digital medicine and digital therapeutics
3.7 Regulatory landscape
- 3.7.1 U.S.
- 3.7.2 Europe
3.8 Reimbursement scenario
- 3.8.1 U.S.
- 3.8.2 Europe
3.9 Investment overview
3.10 Technology trend analysis
3.11 R&D pipeline for leading digital therapeutics companies
3.12 Digital therapeutics use cases per therapeutic area and example applications
3.13 Impact of digital therapeutics on key stakeholders
3.14 Digital Therapeutics-Biopharma deals, 2019
3.15 Porter's analysis
3.16 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021

Chapter 5 Digital Therapeutics Market, By Component

5.1 Key segment trends
5.2 Software
- 5.2.1 Market size, by region, 2018-2032 (USD Million)
5.3 Device
- 5.3.1 Market size ,by region, 2018-2032 (USD Million)

Chapter 6 Digital Therapeutics Market, By Application

6.1 Key segment trends
6.2 Diabetes
- 6.2.1 Market size, by region, 2018-2032 (USD Million)
6.3 Obesity
- 6.3.1 Market size, by region, 2018-2032 (USD Million)
6.4 Cardiovascular
- 6.4.1 Market size, by region, 2018-2032 (USD Million)
6.5 Mental & behavioral health
- 6.5.1 Market size, by region, 2018-2032 (USD Million)
6.6 Hypertension
- 6.6.1 Market size, by region, 2018-2032 (USD Million)
6.7 Insomnia
- 6.7.1 Market size, by region, 2018-2032 (USD Million)
6.8 Others
- 6.8.1 Market size, by region, 2018-2032 (USD Million)

Chapter 7 Digital Therapeutics Market, By Sales channel

7.1 Key segment trends
7.2 Business-to-business (B2B)
- 7.2.1 Market size, by region, 2018-2032 (USD Million)
7.3 Business-to-consumers (B2C)
- 7.3.1 Market size, by region, 2018-2032 (USD Million)

Chapter 8 Digital Therapeutics Market, By Region

8.1 Key regional trends
8.2 North America
- 8.2.1 Market size, by country, 2018-2032 (USD Million)
- 8.2.2 Market size, by component, 2018-2032 (USD Million)
- 8.2.3 Market size, by application, 2018-2032 (USD Million)
- 8.2.4 Market size, by sales channel, 2018-2032 (USD Million)
- 8.2.5 U.S.
  - 8.2.5.1 Market size, by component, 2018-2032 (USD Million)
  - 8.2.5.2 Market size, by application, 2018-2032 (USD Million)
  - 8.2.5.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.2.6 Canada
  - 8.2.6.1 Market size, by component, 2018-2032 (USD Million)
  - 8.2.6.2 Market size, by application, 2018-2032 (USD Million)
  - 8.2.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3 Europe
- 8.3.1 Market size, by country, 2018-2032 (USD Million)
- 8.3.2 Market size, by component, 2018-2032 (USD Million)
- 8.3.3 Market size, by application, 2018-2032 (USD Million)
- 8.3.4 Market size, by sales channel, 2018-2032 (USD Million)
- 8.3.5 Germany
  - 8.3.5.1 Market size, by component, 2018-2032 (USD Million)
  - 8.3.5.2 Market size, by application, 2018-2032 (USD Million)
  - 8.3.5.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.3.6 UK
  - 8.3.6.1 Market size, by component, 2018-2032 (USD Million)
  - 8.3.6.2 Market size, by application, 2018-2032 (USD Million)
  - 8.3.6.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.3.7 France
  - 8.3.7.1 Market size, by component, 2018-2032 (USD Million)
  - 8.3.7.2 Market size, by application, 2018-2032 (USD Million)
  - 8.3.7.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.3.8 Italy
  - 8.3.8.1 Market size, by component, 2018-2032 (USD Million)
  - 8.3.8.2 Market size, by application, 2018-2032 (USD Million)
  - 8.3.8.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.3.9 Spain
  - 8.3.9.1 Market size, by component, 2018-2032 (USD Million)
  - 8.3.9.2 Market size, by application, 2018-2032 (USD Million)
  - 8.3.9.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4 Asia Pacific
- 8.4.1 Market size, by country, 2018-2032 (USD Million)
- 8.4.2 Market size, by component, 2018-2032 (USD Million)
- 8.4.3 Market size, by application, 2018-2032 (USD Million)
- 8.4.4 Market size, by sales channel, 2018-2032 (USD Million)
- 8.4.5 Japan
  - 8.4.5.1 Market size, by component, 2018-2032 (USD Million)
  - 8.4.5.2 Market size, by application, 2018-2032 (USD Million)
  - 8.4.5.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.4.6 China
  - 8.4.6.1 Market size, by component, 2018-2032 (USD Million)
  - 8.4.6.2 Market size, by application, 2018-2032 (USD Million)
  - 8.4.6.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.4.7 India
  - 8.4.7.1 Market size, by component, 2018-2032 (USD Million)
  - 8.4.7.2 Market size, by application, 2018-2032 (USD Million)
  - 8.4.7.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.4.8 Australia
  - 8.4.8.1 Market size, by component, 2018-2032 (USD Million)
  - 8.4.8.2 Market size, by application, 2018-2032 (USD Million)
  - 8.4.8.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.4.9 Singapore
  - 8.4.9.1 Market size, by component, 2018-2032 (USD Million)
  - 8.4.9.2 Market size, by application, 2018-2032 (USD Million)
  - 8.4.9.3 Market size, by sales channel, 2018-2032 (USD Million)
8.5 Latin America
- 8.5.1 Market size, by country, 2018-2032 (USD Million)
- 8.5.2 Market size, by component, 2018-2032 (USD Million)
- 8.5.3 Market size, by application, 2018-2032 (USD Million)
- 8.5.4 Market size, by sales channel, 2018-2032 (USD Million)
- 8.5.5 Mexico
  - 8.5.5.1 Market size, by component, 2018-2032 (USD Million)
  - 8.5.5.2 Market size, by application, 2018-2032 (USD Million)
  - 8.5.5.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.5.6 Brazil
  - 8.5.6.1 Market size, by component, 2018-2032 (USD Million)
  - 8.5.6.2 Market size, by application, 2018-2032 (USD Million)
  - 8.5.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6 MEA
- 8.6.1 Market size, by country, 2018-2032 (USD Million)
- 8.6.2 Market size, by component, 2018-2032 (USD Million)
- 8.6.3 Market size, by application, 2018-2032 (USD Million)
- 8.6.4 Market size, by sales channel, 2018-2032 (USD Million)
- 8.6.5 Saudi Arabia
  - 8.6.5.1 Market size, by component, 2018-2032 (USD Million)
  - 8.6.5.2 Market size, by application, 2018-2032 (USD Million)
  - 8.6.5.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.6.6 South Africa
  - 8.6.6.1 Market size, by component, 2018-2032 (USD Million)
  - 8.6.6.2 Market size, by application, 2018-2032 (USD Million)
  - 8.6.6.3 Market size, by sales channel, 2018-2032 (USD Million)
- 8.6.7 Israel
  - 8.6.7.1 Market size, by component, 2018-2032 (USD Million)
  - 8.6.7.2 Market size, by application, 2018-2032 (USD Million)
  - 8.6.7.3 Market size, by sales channel, 2018-2032 (USD Million)

Chapter 9 Company Profiles

9.1 Otsuka Holdings Co., Ltd.
- 9.1.1 Business overview
- 9.1.2 Financial data
- 9.1.3 Product landscape
- 9.1.4 Strategic outlook
- 9.1.5 SWOT analysis
9.2 Propeller Health (ResMed)
- 9.2.1 Business overview
- 9.2.2 Financial data
- 9.2.3 Product landscape
- 9.2.4 Strategic outlook
- 9.2.5 SWOT analysis
9.3 Virta Health Corp
- 9.3.1 Business overview
- 9.3.2 Financial data
- 9.3.3 Product landscape
- 9.3.4 Strategic outlook
- 9.3.5 SWOT analysis
9.4 Teladoc Health
- 9.4.1 Business overview
- 9.4.2 Financial data
- 9.4.3 Product landscape
- 9.4.4 Strategic outlook
- 9.4.5 SWOT analysis
9.5 Pear Therapeutics Inc
- 9.5.1 Business overview
- 9.5.2 Financial data
- 9.5.3 Product landscape
- 9.5.4 Strategic outlook
- 9.5.5 SWOT analysis
9.6 Omada Health Inc
- 9.6.1 Business overview
- 9.6.2 Financial data
- 9.6.3 Product landscape
- 9.6.4 Strategic outlook
- 9.6.5 SWOT analysis
9.7 Akili Interactive Labs
- 9.7.1 Business overview
- 9.7.2 Financial data
- 9.7.3 Product landscape
- 9.7.4 Strategic outlook
- 9.7.5 SWOT analysis
9.8 WellDoc, Inc.
- 9.8.1 Business overview
- 9.8.2 Financial data
- 9.8.3 Product landscape
- 9.8.4 Strategic outlook
- 9.8.5 SWOT analysis
9.9 Click Therapeutics
- 9.9.1 Business overview
- 9.9.2 Financial data
- 9.9.3 Product landscape
- 9.9.4 Strategic outlook
- 9.9.5 SWOT analysis
9.10 Biofourmis, Inc.
- 9.10.1 Business overview
- 9.10.2 Financial data
- 9.10.3 Product landscape
- 9.10.4 Strategic outlook
- 9.10.5 SWOT analysis
9.11 Lark Health
- 9.11.1 Business overview
- 9.11.2 Financial data
- 9.11.3 Product landscape
- 9.11.4 Strategic outlook
- 9.11.5 SWOT analysis
9.12 LifeScan, Inc.
- 9.12.1 Business overview
- 9.12.2 Financial data
- 9.12.3 Product landscape
- 9.12.4 Strategic outlook
- 9.12.5 SWOT analysis
9.13 DarioHealth
- 9.13.1 Business overview
- 9.13.2 Financial data
- 9.13.3 Product landscape
- 9.13.4 Strategic outlook
- 9.13.5 SWOT analysis
9.14 Voluntis
- 9.14.1 Business overview
- 9.14.2 Financial data
- 9.14.3 Product landscape
- 9.14.4 Strategic outlook
- 9.14.5 SWOT analysis
9.15 My Sugr (Roche)
- 9.15.1 Business overview
- 9.15.2 Financial data
- 9.15.3 Product landscape
- 9.15.4 Strategic outlook
- 9.15.5 SWOT analysis

簡介目錄圖表

Data Tables

TABLE 1. Global digital therapeutics market, 2018 - 2024 (USD Million)
TABLE 2. Global digital therapeutics market, 2025 - 2032 (USD Million)
TABLE 3. Global digital therapeutics market, by component, 2018 - 2024 (USD Million)
TABLE 4. Global digital therapeutics market, by component, 2025 - 2032 (USD Million)
TABLE 5. Global digital therapeutics market, by application, 2018 - 2024 (USD Million)
TABLE 6. Global digital therapeutics market, by application, 2025 - 2032 (USD Million)
TABLE 7. Global digital therapeutics market, by sales channels, 2018 - 2024 (USD Million)
TABLE 8. Global digital therapeutics market, by sales channels, 2025 - 2032 (USD Million)
TABLE 9. Global digital therapeutics market, by region, 2018 - 2024 (USD Million)
TABLE 10. Global digital therapeutics market, by region, 2025 - 2032 (USD Million)
TABLE 11. Industry impact forces
TABLE 12. Software market, by region, 2018 - 2024 (USD Million)
TABLE 13. Software market, by region, 2025 - 2032 (USD Million)
TABLE 14. Devices market, by region, 2018 - 2024 (USD Million)
TABLE 15. Devices market, by region, 2025 - 2032 (USD Million)
TABLE 16. Diabetes market, by region, 2018 - 2024 (USD Million)
TABLE 17. Diabetes market, by region, 2025 - 2032 (USD Million)
TABLE 18. Obesity market, by region, 2018 - 2024 (USD Million)
TABLE 19. Obesity market, by region, 2025 - 2032 (USD Million)
TABLE 20. Cardiovascular market, by region, 2018 - 2024 (USD Million)
TABLE 21. Cardiovascular market, by region, 2025 - 2032 (USD Million)
TABLE 22. Mental & behavioral health market, by region, 2018 - 2024 (USD Million)
TABLE 23. Mental & behavioral health market, by region, 2025 - 2032 (USD Million)
TABLE 24. Hypertension market, by region, 2018 - 2024 (USD Million)
TABLE 25. Hypertension market, by region, 2025 - 2032 (USD Million)
TABLE 26. Insomnia market, by region, 2018 - 2024 (USD Million)
TABLE 27. Insomnia market, by region, 2025 - 2032 (USD Million)
TABLE 28. Others market, by region, 2018 - 2024 (USD Million)
TABLE 29. Others market, by region, 2025 - 2032 (USD Million)
TABLE 30. Business-to-business (B2B) market, by region, 2018 - 2024 (USD Million)
TABLE 31. Business-to-business (B2B) market, by region, 2025 - 2032 (USD Million)
TABLE 32. Business-to-consumers (B2C) market, by region, 2018 - 2024 (USD Million)
TABLE 33. Business-to-consumers (B2C) market, by region, 2025 - 2032 (USD Million)
TABLE 34. North America digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 35. North America digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 36. North America digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 37. North America digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 38. North America digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 39. North America digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 40. North America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 41. North America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 42. U.S. digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 43. U.S. digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 44. U.S. digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 45. U.S. digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 46. U.S. digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 47. U.S. digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 48. Canada digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 49. Canada digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 50. Canada digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 51. Canada digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 52. Canada digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 53. Canada digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 54. Europe digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 55. Europe digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 56. Europe digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 57. Europe digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 58. Europe digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 59. Europe digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 60. Europe digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 61. Europe digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 62. Germany digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 63. Germany digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 64. Germany digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 65. Germany digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 66. Germany digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 67. Germany digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 68. UK digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 69. UK digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 70. UK digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 71. UK digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 72. UK digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 73. UK digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 74. France digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 75. France digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 76. France digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 77. France digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 78. France digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 79. France digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 80. Italy digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 81. Italy digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 82. Italy digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 83. Italy digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 84. Italy digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 85. Italy digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 86. Spain digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 87. Spain digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 88. Spain digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 89. Spain digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 90. Spain digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 91. Spain digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 92. Asia Pacific digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 93. Asia Pacific digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 94. Asia Pacific digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 95. Asia Pacific digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 96. Asia Pacific digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 97. Asia Pacific digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 98. Asia Pacific digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 99. Asia Pacific digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 100. Japan digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 101. Japan digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 102. Japan digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 103. Japan digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 104. Japan digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 105. Japan digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 106. China digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 107. China digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 108. China digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 109. China digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 110. China digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 111. China digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 112. India digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 113. India digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 114. India digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 115. India digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 116. India digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 117. India digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 118. Australia digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 119. Australia digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 120. Australia digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 121. Australia digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 122. Australia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 123. Australia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 124. Singapore digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 125. Singapore digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 126. Singapore digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 127. Singapore digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 128. Singapore digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 129. Singapore digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 130. Latin America digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 131. Latin America digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 132. Latin America digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 133. Latin America digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 134. Latin America digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 135. Latin America digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 136. Latin America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 137. Latin America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 138. Brazil digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 139. Brazil digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 140. Brazil digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 141. Brazil digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 142. Brazil digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 143. Brazil digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 144. Mexico digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 145. Mexico digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 146. Mexico digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 147. Mexico digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 148. Mexico digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 149. Mexico digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 150. MEA digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 151. MEA digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 152. MEA digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 153. MEA digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 154. MEA digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 155. MEA digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 156. MEA digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 157. MEA digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 158. Saudi Arabia digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 159. Saudi Arabia digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 160. Saudi Arabia digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 161. Saudi Arabia digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 162. Saudi Arabia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 163. Saudi Arabia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 164. South Africa digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 165. South Africa digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 166. South Africa digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 167. South Africa digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 168. South Africa digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 169. South Africa digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 170. Israel digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 171. Israel digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 172. Israel digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 173. Israel digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 174. Israel digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 175. Israel digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)